Skip to main content
. 2022 Aug 8;66(4):426–437. doi: 10.1002/mus.27681

TABLE 2.

Comparison of vaccination‐related ADEs among active and inactive IIM cases

Active IIM a (n = 855) Inactive IIM a (n = 352) Univariate Multivariable
OR (95% CI) P value OR (95% CI) P value
Any ADE 681 (79.6) 242 (68.8) 1.7 (1.3‐2.3) <.001 1.6 (1.1‐2.2) .006
Injection site pain 557 (65) 216 (61) .213
Minor ADEs
Any minor ADE 679 (79.4) 242 (68.8) 1.7 (1.3‐2.3) <.001 1.5 (1.1‐2.2) .007
Myalgia 117 (13.7) 25 (7) 2 (1.3‐3.2) .001 2.2 (1.3‐3.8) .002
Body ache 178 (21) 49 (14) 1.6 (1.1‐2.2) .005 1.5 (1.07‐2.3) .020
Fever 112 (13) 37 (10.5) ‐‐‐ .214
Chills 134 (15.7) 38 (10.8) 1.5 (1.04‐2.2) .028 1.3 (0.8‐2.1) .162
Nausea and vomiting 60 (7) 12 (3.4) 2.1 (1.1‐4) .016 1.7 (0.8‐3.6) .107
Headache 212 (25) 55 (15.6) 1.7 (1.2‐2.4) <.001 1.5 (1.04‐2.1) .028
Rashes 25 (2.9) 9 (2.6) .726
Fatigue 266 (31.1) 73 (20.7) 1.7 (1.2‐2.3) <.001 1.5 (1.08‐2.1) .015
Diarrhea 22 (2.6) 5 (1.4) .218
Abdominal pain 24 (2.8) 3 (0.9) .051
High pulse rate or palpitations 21 (2.5) 6 (1.7) .422
Rise in blood pressure 5 (0.6) 3 (0.9) .603
Fainting 2 (0.2) 2 (0.6) .358
Difficulty in breathing 9 (1.1) 1 (0.3) .181
Dizziness 51 (6) 7 (2) 3.1 (1.4‐6.9) .003 2.5 (1.08‐5.9) .031
Chest pain 14 (1.6) 2 (0.6) .140
Major ADEs
Any major ADE 49 (5.7) 6 (1.7) 3.5 (1.4‐8.2) .002 2.7 (1.04‐7.3) .040
Anaphylaxis 5 (0.6) 0 (0) .151
Marked difficulty in breathing 5 (0.6) 3 (0.9) .603
Throat closure 4 (0.5) 0 (0) .199
Severe rashes 7 (0.8) 1 (0.3) .298
Hospitalization 5 (0.6) 2 (0.6) .972

Notes: Chi‐square test was used for categorical variables and Mann‐Whitney U test used for continuous variables.

Factors adjusted in multivariable analysis (binary logistic regression) include age, gender, ethnicity, vaccine received, number of vaccine doses received, and immunosuppressants received.

Abbreviations: ADE, adverse drug event; CI, confidence interval; IIM, idiopathic inflammatory myopathy; OR, odds ratio.

a

Data expressed as number (%).